Phibro Animal Health Corp financial data

Symbol
PAHC on Nasdaq
Location
Glenpointe Centre East, 3 Rd Floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ
State of incorporation
DE
Fiscal year end
June 30
Former names
PHILIPP BROTHERS CHEMICALS INC (to 5/14/2003)
Latest financial report
10-Q - Q4 2024 - Feb 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 313 % -6.25%
Quick Ratio 155 % -4.11%
Debt-to-equity 308 % +22%
Return On Equity 7.49 % +39%
Return On Assets 1.83 % +20.3%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 235M USD -13.6%
Weighted Average Number of Shares Outstanding, Basic 40.5M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 40.7M shares +0.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.11B USD +12.6%
Operating Income (Loss) 81.6M USD +42.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 33.8M USD +20.1%
Income Tax Expense (Benefit) 14.5M USD +8.54%
Net Income (Loss) Attributable to Parent 19.3M USD +30.5%
Earnings Per Share, Basic 0.48 USD/shares +33.3%
Earnings Per Share, Diluted 0.48 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.1M USD +103%
Accounts Receivable, after Allowance for Credit Loss, Current 192M USD +27.3%
Inventory, Net 427M USD +49%
Other Assets, Current 60.1M USD +5.78%
Assets, Current 746M USD +27.2%
Deferred Income Tax Assets, Net 33.8M USD +139%
Property, Plant and Equipment, Net 338M USD +68.1%
Operating Lease, Right-of-Use Asset 37.4M USD -2.1%
Goodwill 54.5M USD -0.25%
Other Assets, Noncurrent 107M USD +34.7%
Assets 1.29B USD +32.2%
Accounts Payable, Current 99.4M USD +15.1%
Employee-related Liabilities, Current 34.7M USD +26.6%
Contract with Customer, Liability, Current 370K USD -55%
Liabilities, Current 233M USD +24.2%
Deferred Income Tax Liabilities, Net 667K USD -61.1%
Operating Lease, Liability, Noncurrent 28.3M USD -9.23%
Other Liabilities, Noncurrent 68.6M USD +4.99%
Liabilities 1.04B USD +48%
Accumulated Other Comprehensive Income (Loss), Net of Tax -134M USD -22.4%
Retained Earnings (Accumulated Deficit) 244M USD -0.05%
Stockholders' Equity Attributable to Parent 247M USD -8.86%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 247M USD -8.86%
Liabilities and Equity 1.29B USD +32.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 12.6M USD -22.1%
Net Cash Provided by (Used in) Financing Activities -29.2M USD -2353%
Net Cash Provided by (Used in) Investing Activities -2.93M USD +80.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.8M USD -1103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 67.1M USD +103%
Deferred Tax Assets, Valuation Allowance 1.29M USD -50.4%
Deferred Tax Assets, Gross 40.7M USD +64.4%
Operating Lease, Liability 37.4M USD +6.39%
Depreciation 29.8M USD +18.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5.23M USD -124%
Lessee, Operating Lease, Liability, to be Paid 45.3M USD +5.78%
Property, Plant and Equipment, Gross 449M USD -2.3%
Operating Lease, Liability, Current 8.02M USD +14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.09M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.8M USD +23.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +25.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.89M USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.21M USD +12.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 16M shares 0%
Unrecognized Tax Benefits 11.9M USD +25.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.92M USD +15.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.18M USD -6.09%
Depreciation, Depletion and Amortization 39M USD +11.9%
Deferred Tax Assets, Net of Valuation Allowance 39.4M USD +77.8%
Interest Expense 22.5M USD +35%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%